When is it appropriate to reduce acid-suppressing medication, and how can clinicians support safe, gradual deprescribing while minimising withdrawal effects and long-term pharmaceutical risks?
In this session, Compounding Pharmacist and Naturopath Diana Boot explores the pharmacology of acid-suppressing medicines and explains the physiological mechanisms underlying rebound acid hypersecretion and withdrawal symptoms.
Diana will review evidence-based natural medicines for the management of gastro-oesophageal reflux disease (GORD), with a focus on restoring healthy gastric function rather than long-term acid suppression. Available compounding ingredients—including alginate, aloe vera, slippery elm, prebiotics and zinc carnosine—will be discussed in detail, highlighting their mechanisms of action, clinical benefits and key areas of caution.
The session will conclude with a practical, step-by-step guide to designing bespoke compounded prescriptions, enabling clinicians to individualise reflux management and support patients through responsible deprescribing.
Learning Outcomes
By the end of this session, participants will be able to:
- Identify appropriate clinical scenarios for reducing or deprescribing acid-suppressing medications
- Explain the pharmacology of reflux medicines and the physiological drivers of rebound acid hypersecretion
- Evaluate the evidence supporting natural and compounded therapies for gastro-oesophageal reflux
- Select appropriate compounding ingredients and recognise contraindications and cautions
- Design an individualised, patient-centred compounded prescription to support safe reflux management and gastric function restoration
Join Diana Boot for the webinar 'Responsible Reduction of Reliance on Reflux Medicines.'
Proudly sponsored by
